These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18317830)

  • 1. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.
    Boschi F; Marzola P; Sandri M; Nicolato E; Galiè M; Fiorini S; Merigo F; Lorusso V; Chaabane L; Sbarbati A
    MAGMA; 2008 May; 21(3):169-76. PubMed ID: 18317830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents.
    Marzola P; Ramponi S; Nicolato E; Lovati E; Sandri M; Calderan L; Crescimanno C; Merigo F; Sbarbati A; Grotti A; Vultaggio S; Cavagna F; Lorusso V; Osculati F
    Invest Radiol; 2005 Jul; 40(7):421-9. PubMed ID: 15973133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent.
    Wikström MG; Moseley ME; White DL; Dupon JW; Winkelhake JL; Kopplin J; Brasch RC
    Invest Radiol; 1989 Aug; 24(8):609-15. PubMed ID: 2777530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
    Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
    Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
    Hompland T; Ellingsen C; Rofstad EK
    BMC Cancer; 2012 Nov; 12():544. PubMed ID: 23173554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
    van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
    Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model.
    Kassner A; Thornhill RE; Liu F; Winter PM; Caruthers SD; Wickline SA; Lanza GM
    Contrast Media Mol Imaging; 2010; 5(3):155-61. PubMed ID: 20586031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent.
    Schwickert HC; Roberts TP; Mühler A; Stiskal M; Demsar F; Brasch RC
    Eur J Radiol; 1995 Jul; 20(2):144-50. PubMed ID: 7588870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel macromolecular cascade-polymer contrast medium for dynamic contrast-enhanced MRI monitoring of antiangiogenic bevacizumab therapy in a human melanoma model.
    Cyran CC; Fu Y; Rogut V; Chaopathomkul B; Wendland MF; Shames DM; Brasch RC
    Acad Radiol; 2013 Oct; 20(10):1256-63. PubMed ID: 24029057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.
    Turetschek K; Floyd E; Helbich T; Roberts TP; Shames DM; Wendland MF; Carter WO; Brasch RC
    J Magn Reson Imaging; 2001 Sep; 14(3):237-42. PubMed ID: 11536400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous Enhancement Pattern in DCE-MRI Reveals the Morphology of Normal Lymph Nodes: An Experimental Study.
    Bontempi P; Busato A; Conti G; Della Sala SW; Marzola P; Farace P
    Contrast Media Mol Imaging; 2019; 2019():4096706. PubMed ID: 31089325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure.
    Marzola P; Farace P; Calderan L; Crescimanno C; Lunati E; Nicolato E; Benati D; Degrassi A; Terron A; Klapwijk J; Pesenti E; Sbarbati A; Osculati F
    Int J Cancer; 2003 Apr; 104(4):462-8. PubMed ID: 12584744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA.
    Su MY; Najafi AA; Nalcioglu O
    Magn Reson Med; 1995 Sep; 34(3):402-11. PubMed ID: 7500880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.